Indefinite Delivery Contract VA25016D0060
Award Date
9/30/21
Last Date to Order
9/30/21
Federal Agency
Veterans Integrated Service Network 10
Awardee
Schaaf Drugs, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration awarded a single-award, firm-fixed price indefinite-delivery/indefinite-quantity contract with a potential value of $3,888,886.25 to Schaaf Drugs, LLC doing business as Heartlight Pharmacy Services to provide radiopharmaceutical products and delivery services in support of nuclear medicine procedures at the Dayton VA Medical Center in Lima, Ohio. The base period of performance is from October 1, 2021 through September 30, 2026,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 (VA-VHA VISN 10) awarded an indefinite delivery contract to Schaaf Drugs, LLC doing business as Heartlight Pharmacy Services to provide radiopharmaceutical drugs. The contract has a potential value of $3,249,071.28 over a five year period of performance from November 2022 to November 2027. No set asides were used. Two delivery orders have been issued against this contract. The first is a firm...
The U.S. Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Schaaf Drugs, LLC, doing business as Heartlight Pharmacy Services, a for-profit limited liability company based in Lima, Ohio. The contract, valued at up to $604,977.60, is for the provision of radiopharmaceutical drugs, radioactive isotopes, and associated delivery services to VA medical facilities within the Veterans Integrated Service Network 10 (VISN 10) region covering Ohio and Indiana. This IDC...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded an indefinite delivery contract to Schaaf Drugs, LLC doing business as Heartlight Pharmacy Services to provide radioactive isotopes. The contract has a potential value of $339,599 and a period of performance from October 1, 2022 through September 30, 2027. Two delivery orders have been issued against the contract. The first is for $66,736.50 to provide radioactive isotopes in Lima,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a single-award indefinite-delivery contract to Cardinal Health 414, LLC to provide radiopharmaceutical products and delivery services in support of the Louis Stokes Cleveland VA Medical Center. The contract has a potential value of $1,848,580.35 over a five-year period of performance from October 1, 2021 to September 30, 2026. Task orders issued against the contract include the...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a single award, indefinite delivery contract valued at up to $1.3 million to Cardinal Health 414, LLC for the delivery of radiopharmaceutical products to the Huntington VA Medical Center in Dublin, Ohio. The prime contractor was selected to provide ready-to-use unit dose radiopharmaceutical products over a five year ordering period from October 2022 through September 2027 to support...
The Department of Veterans Affairs Veterans Health Administration awarded Cardinal Health 414, LLC an indefinite delivery contract for radiopharmaceuticals with a potential value of $785,752.02. Task orders issued against the contract include a $429,098 firm fixed price delivery order for performance from October 1, 2023 through September 30, 2024 in Dublin, Ohio, and a $186,635 firm fixed price delivery order for performance through November 21, 2023. The originating pre-solicitation notice...
The Department of Veterans Affairs Veterans Health Administration awarded a single award Indefinite Delivery Contract to Cardinal Health 414, LLC for radiopharmaceuticals. Over the five year period of performance from April 2020 to March 2025, the contract has a potential value of $5,000,000. Delivery orders have been issued on an annual basis for quantities of radiopharmaceuticals to support diagnostic imaging services provided by VHA medical centers in Veterans Integrated Service Network 21....
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded Cardinal Health 414, LLC a single award indefinite delivery contract with a potential value of $417,688.32 to supply radiopharmaceuticals. Two firm fixed price delivery orders against the contract total $257,836.53 to supply medical isotopes for nuclear medicine diagnostic services to VA medical facilities in central Ohio through March 2025. The originating pre-solicitation sought...
The Department of Veterans Affairs Veterans Health Administration awarded an indefinite-delivery/indefinite-quantity contract to Cardinal Health 414, LLC to provide radiopharmaceuticals to Veterans Integrated Service Network 2 facilities. The prime contractor will supply radioactive drugs to support nuclear medicine diagnostic services for veterans in Syracuse, New York and Dublin, Ohio under delivery orders valued at approximately $887,480 over multiple years. The contract was awarded on...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order VA25016D0060-36C25021N0049 | Schaaf Drugs, LLC | $3.1m | 10/1/20 | 9/30/21 | 10/1/20 | |
Delivery Order VA25016D0060-36C25020N0040 | Schaaf Drugs, LLC | $750.7k | 10/1/19 | 9/30/20 | 10/1/19 | |
Delivery Order VA25016D0060-36C25018F0003 | Schaaf Drugs, LLC | $3.4m | 10/1/17 | 9/30/18 | 10/3/17 | |
Delivery Order VA25016D0060-36C25019N0023 | Schaaf Drugs, LLC | $3.4m | 10/1/18 | 9/30/19 | 10/2/18 | |
Delivery Order VA25016D0060-VA25017J0003 | Schaaf Drugs, LLC | $3.4m | 10/1/16 | 9/30/17 | 4/10/17 |